Effect of Preoperative CIMT on Hemodynamics During Liver Transplantation
Recruiting
Observational Study
Liver Transplantation
Carotid Intima-media Thickness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 54 (estimated)
- Sponsor
- Dicle University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Candidates for liver transplantation (CT) carry an increased risk of cardiovascular disease (CVD) due to underlying end-stage liver disease (ESHD) and immunosuppressive drugs used post-transplantation. CVD is a significant cause of long-term mortality after CT \[1\] \[2\]. Carotid Intima-Media Thickness (CIMT), a subclinical marker of atherosclerosis in the preoperative period, is a non-invasive m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged between 18 and 65 years
* Scheduled for elective liver transplantation surgery
* Completed preoperative carotid intima-media thickness (CIMT) ultrasonographic measurement
* Patients with signed informed consent for data collection
Exclusion Criteria:
* Patients…
Contacts